NASDAQ:CLLS

Cellectis Shares Dip Ahead of June Data Investors Wait For
····

Cellectis Shares Dip Ahead of June Data Investors Wait For

Cellectis ADRs fell 2.3% to $3.44 Monday amid a broader biotech downturn, with no new company disclosures. The firm plans to present Phase 1 data for its CD22-targeting CAR-T therapy at the European Hematology Association meeting on June 13. Cellectis reported $188 million in cash as of March 31, projecting funding into late 2027. Barclays initiated coverage last week with an overweight rating and a $9 target.
June 1, 2026

Stock Market Today

  • Victorian government to tighten IVF clinic regulation after Monash IVF errors
    June 1, 2026, 8:32 PM EDT. The Victorian government plans stricter regulations for IVF clinics following high-profile embryo mix-ups involving Monash IVF. Health Minister Harriet Shing will gain authority to cancel clinic registrations and enforce rigorous accreditation standards under a national framework led by the Australian Commission on Safety and Quality in Health Care. The moves aim to address inconsistencies in state regulations and improve patient safety with measures like performance metrics, workforce guidelines, and safety rules for new technologies. Clinics will face a standard three-year registration, subject to review or shortening if risks are identified. Additional powers include health department inspections and equipment seizures. The changes follow a government-initiated review revealing significant shortcomings in the IVF sector.